Pharmaceutical Company Executives Discuss Future Of Lower Profits

Financial Times: Pharma giants see future of lower health care profits
“For the hundreds of executives gathered in London recently for the FT’s annual pharmaceutical conference, the words of GlaxoSmithKline chief Sir Andrew Witty highlighted the problems facing the industry in the decades ahead. Despite pouring many billions of dollars into new treatments and extending lives in ways that were merely a dream a few years ago, drugmakers may have to get used to making less money. … The social contract between citizens and pharmaceutical companies — rocked by a string of recent pricing scandals — is fraying…” The article is part of a special report titled “Innovation in Healthcare” (Viña, 11/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.